Smith Chas P & Associates PA Cpas Lowers Holdings in Colgate-Palmolive (NYSE:CL)

Smith Chas P & Associates PA Cpas decreased its stake in Colgate-Palmolive (NYSE:CL) by 8.4% during the third quarter, Holdings Channel reports. The institutional investor owned 59,359 shares of the company’s stock after selling 5,437 shares during the quarter. Smith Chas P & Associates PA Cpas’ holdings in Colgate-Palmolive were worth $4,363,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Buckingham Capital Management Inc. increased its position in shares of Colgate-Palmolive by 0.5% in the first quarter. Buckingham Capital Management Inc. now owns 34,514 shares of the company’s stock worth $2,366,000 after purchasing an additional 183 shares during the last quarter. Deane Retirement Strategies Inc. increased its position in shares of Colgate-Palmolive by 1.4% in the second quarter. Deane Retirement Strategies Inc. now owns 30,431 shares of the company’s stock worth $2,181,000 after purchasing an additional 420 shares during the last quarter. Swedbank increased its position in shares of Colgate-Palmolive by 1.2% in the second quarter. Swedbank now owns 2,202,863 shares of the company’s stock worth $157,880,000 after purchasing an additional 26,800 shares during the last quarter. Rockland Trust Co. increased its position in shares of Colgate-Palmolive by 2.6% in the second quarter. Rockland Trust Co. now owns 150,674 shares of the company’s stock worth $10,799,000 after purchasing an additional 3,764 shares during the last quarter. Finally, WINTON GROUP Ltd increased its position in shares of Colgate-Palmolive by 10.3% in the second quarter. WINTON GROUP Ltd now owns 727,968 shares of the company’s stock worth $52,173,000 after purchasing an additional 68,192 shares during the last quarter. Hedge funds and other institutional investors own 76.19% of the company’s stock.

Shares of NYSE:CL traded up $0.10 during trading on Tuesday, reaching $66.64. 3,120,400 shares of the company traded hands, compared to its average volume of 3,530,417. The firm has a market capitalization of $57.10 billion, a price-to-earnings ratio of 22.44, a P/E/G ratio of 5.29 and a beta of 0.73. Colgate-Palmolive has a 52-week low of $57.51 and a 52-week high of $76.41. The company has a current ratio of 1.03, a quick ratio of 0.70 and a debt-to-equity ratio of 43.94. The business’s fifty day moving average is $69.31 and its 200-day moving average is $71.54.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, November 1st. The company reported $0.71 earnings per share for the quarter, beating analysts’ consensus estimates of $0.70 by $0.01. The firm had revenue of $3.93 billion during the quarter, compared to analyst estimates of $3.95 billion. Colgate-Palmolive had a return on equity of 6,492.71% and a net margin of 15.04%. The business’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.72 earnings per share. On average, sell-side analysts predict that Colgate-Palmolive will post 2.83 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Wednesday, October 23rd will be paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.58%. The ex-dividend date of this dividend is Tuesday, October 22nd. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.91%.

Several research firms recently weighed in on CL. Wells Fargo & Co upped their price objective on shares of Colgate-Palmolive from $68.00 to $70.00 and gave the stock a “market perform” rating in a research report on Monday, July 29th. JPMorgan Chase & Co. decreased their price objective on shares of Colgate-Palmolive from $76.00 to $71.00 and set a “neutral” rating on the stock in a research report on Monday, November 4th. Piper Jaffray Companies began coverage on shares of Colgate-Palmolive in a research report on Tuesday, August 13th. They issued an “overweight” rating on the stock. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $70.00 price objective on the stock. in a research report on Monday, November 4th. Finally, Citigroup upped their target price on Colgate-Palmolive from $77.00 to $79.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 20th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $72.57.

In related news, Chairman Ian M. Cook sold 17,750 shares of the firm’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $68.72, for a total value of $1,219,780.00. Following the completion of the sale, the chairman now owns 1,029,785 shares of the company’s stock, valued at $70,766,825.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman Ian M. Cook sold 19,500 shares of the stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $73.97, for a total value of $1,442,415.00. Following the completion of the transaction, the chairman now owns 1,088,367 shares of the company’s stock, valued at approximately $80,506,506.99. The disclosure for this sale can be found here. In the last three months, insiders have sold 118,986 shares of company stock valued at $8,439,965. Insiders own 1.14% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Read More: Earnings Per Share

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.